Astellas Pharma Japan sedol 69's ticker is and the CUSIP is J03393105. A total of 1 filers reported holding Astellas Pharma Japan sedol 69 in Q3 2017. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $228,000 | -25.7% | 17,600 | 0.0% | 0.08% | -7.8% |
| Q3 2018 | $307,000 | -91.1% | 17,600 | -92.2% | 0.09% | -91.2% |
| Q2 2018 | $3,439,000 | -10.2% | 225,566 | -10.5% | 1.03% | +3.3% |
| Q1 2018 | $3,830,000 | +2.6% | 252,066 | -13.9% | 0.99% | +17.2% |
| Q4 2017 | $3,732,000 | -9.6% | 292,600 | -9.8% | 0.85% | -12.6% |
| Q3 2017 | $4,127,000 | -22.3% | 324,500 | -25.2% | 0.97% | -27.6% |
| Q2 2017 | $5,310,000 | -9.0% | 434,075 | -2.1% | 1.34% | -9.2% |
| Q1 2017 | $5,833,000 | +1850.8% | 443,400 | +1962.3% | 1.48% | +1792.3% |
| Q4 2016 | $299,000 | -12.6% | 21,500 | -2.3% | 0.08% | -29.1% |
| Q3 2016 | $342,000 | +2.1% | 22,000 | +2.3% | 0.11% | +18.3% |
| Q2 2016 | $335,000 | +17.1% | 21,500 | 0.0% | 0.09% | +14.8% |
| Q1 2016 | $286,000 | -7.4% | 21,500 | 0.0% | 0.08% | 0.0% |
| Q4 2015 | $309,000 | +11.6% | 21,500 | 0.0% | 0.08% | 0.0% |
| Q3 2015 | $277,000 | -9.8% | 21,500 | 0.0% | 0.08% | -1.2% |
| Q2 2015 | $307,000 | -13.0% | 21,500 | 0.0% | 0.08% | -15.5% |
| Q1 2015 | $353,000 | +20.5% | 21,500 | 0.0% | 0.10% | +18.3% |
| Q4 2014 | $293,000 | -8.4% | 21,500 | 0.0% | 0.08% | -12.8% |
| Q3 2014 | $320,000 | -6.4% | 21,500 | -17.3% | 0.09% | -6.9% |
| Q2 2014 | $342,000 | +14.4% | 26,000 | +400.0% | 0.10% | +7.4% |
| Q1 2014 | $299,000 | -95.4% | 5,200 | -95.3% | 0.09% | -94.9% |
| Q4 2013 | $6,528,000 | +15.1% | 110,900 | -0.3% | 1.84% | +6.3% |
| Q3 2013 | $5,670,000 | -5.0% | 111,275 | +1.2% | 1.74% | -16.0% |
| Q2 2013 | $5,967,000 | – | 109,975 | – | 2.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ZEVIN ASSET MANAGEMENT LLC | 324,500 | $4,127,000 | 0.97% |